A novel risk-scoring system to identify the potential population benefiting from adjuvant chemotherapy for node-negative tnbc patients with tumor size less than 1 cm

HIGHLIGHTS

• who: Yijun Li from the Xiu2019an Jiaotong University from July , to December , forAuna Oncosalud, Peru have published the article: A Novel Risk-Scoring System to Identify the Potential Population Benefiting From Adjuvant Chemotherapy for Node-Negative TNBC Patients With Tumor Size Less Than 1 cm, in the Journal: (JOURNAL)
• what: The authors conducted a retrospective study to explore the survival benefit from adjuvant chemotherapy for TNBC patients with node-negative and tumor size less than 1 cm using the SEER database.
• how: The authors applied Pearson`s c2 test to compare baseline differences . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.